Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient

FI: 2,2
Type: Article

Home · TEC02-Hospital Pharmacotherapeutic Follow-up

Artículo original

Year: 2025

Brands

Alarcón-Payer, C; Suárez, MDS; Roldán, AM; Morales, AJ

Magazine

Title: ANTI-CANCER DRUGS

Quartile

Q3